Niagen Bioscience Inc.

06/29/2026 | Press release | Distributed by Public on 06/29/2026 14:31

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.
Set forth below are the results of the matters submitted for a vote of stockholders at the Company's 2026 Annual Meeting.
Proposal 1 - Election of directors.
The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.
Director Elected For Withheld Broker Non-Votes
Frank L. Jaksch, Jr. 44,531,507 759,870 13,274,979
Robert Fried 44,822,825 468,552 13,274,979
Steven Rubin 28,495,147 16,796,230 13,274,979
Wendy Yu 44,520,972 770,405 13,274,979
Gary Ng 44,446,052 845,325 13,274,979
Kristin Patrick 43,608,014 1,683,363 13,274,979
Ann Cohen 44,360,218 931,159 13,274,979
Hamed Shahbazi 30,544,086 14,747,291 13,274,979
Proposal 2 - Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
For Against Abstain Broker Non-Votes
56,152,066 2,256,090 158,200 -
* No broker non-votes arose in connection with Proposal 2.
Proposal 3 - Approval, on an advisory basis, of the compensation paid to the Company's named executive officers.
For Against Abstain Broker Non-Votes
43,188,958 1,930,441 171,978 13,274,979
Niagen Bioscience Inc. published this content on June 29, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 29, 2026 at 20:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]